Oncogenes, cancer and analytical cytology.

Abstract

CytometryVolume 7, Issue 5 p. 400-410 Review ArticleFree Access Oncogenes, cancer and analytical cytology† James V. Watson, James V. Watson MRC Clinical Oncology Unit, The Medical School, Hills Road, Cambridge, CB2 2QH EnglandSearch for more papers by this author James V. Watson, James V. Watson MRC Clinical Oncology Unit, The Medical School, Hills Road, Cambridge, CB2 2QH EnglandSearch for more papers by this author First published: September 1986 https://doi.org/10.1002/cyto.990070503Citations: 28 † Since this paper was submitted the onc-D gene has been shown to encode a cytoskeletal tropomyocin fused with tyrosine kinase sequences (Martin-Zanca D, Hughes SH, Barbacid M: Nature 319:743–748, 1986) and the estrogen receptor has been found to be encoded by v-erb-A (Green S, Walter P, Kurman V, Krust A, Bornert JM, Argos P, Chambon P: Nature 320:134–139, 1986). AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Literature Cited 1 Al I, Ploem JS: Detection of suspicious cells and rejection of artefacts in cervical cytology using the Leyden Television Analysis system. J Histochem Cytochem 27: 629– 634, 1979 2 Balmain A, Ramsden M, Bowden GT, Smith J: Activation of the mouse Harvey-ras gene in chemically induced benign skin papillomas. Nature 307: 658– 660, 1984 3 Baltimore D: RNA-dependent DNA polymerase in virons of RNA tumour viruses. Nature 226: 1209– 1211, 1970 4 Bauer KD, Clevinger CV: Nuclear antigens as markers of cell growth, proliferation and differentiation. 11th International Conference of Analytical Cytology, Hilton Head, SC, November, 1985 5 Beckner SK, Hattori S, Shih TY: The ras oncogene product p21 is not a regulatory component of adenylate cyclase. Nature 371: 71– 72, 1985 6 Betsholtz C, Wetermark B, Ek B, Heidin CH: Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implications for autocrine receptor activation. Cell 39: 447– 457, 1984 7 Bishop JM: Trends in ocogenes. Trends Genet 1: 245– 249, 1984 8 Bishop JM: Viral oncogenes. Cell 32: 23– 36, 1985 9 Bishop JM, Varmus H: Functions and origins of retroviral transforming genes. In: Molecular Biology of Tumour Viruses, Part III, RNA Tumour Viruses, R Weiss, N Teich, H Varmus, J Coffin, (eds) Cold Spring Harbor Press, New York, 1982, pp 999– 1108 10 Blanchard J-M, Piechaczyk M, Dani C, Chambard J-C, Franchi A, Pouyssegur J, Jeanteur P: c-myc gene is transcribed in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317: 443– 445, 1985 11 Boschek CB, Jockusch BM, Friis RR, Back R, Grundmann E, Bauer H: Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell 24: 175– 184, 1981 12 Chan SYT, Sikora K, Evan GI, Gabri H, Hill F: Detection of a p40 c-myc gene product-related protein in serum and urine of cancer patients. (Submitted for publication), 1986 13 Chan SYT, Evan GI, Ritson A, Watson JV, Wraight P, Sikora K: Localization of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product. Br J Cancer (In press), 1986 14 Coffin JH, Varmus HE, Bishop JM, Essex M, Hardy WD, Martin S, Rosenberg NE, Scolnick EM, Weinberg RA, Vogt PK: Proposal for naming host cell derived inserts in retrovirus genomes. J Virol 40: 953– 957, 1981 15 Cooper GM, Lane MA: Cellular transforming genes and oncogenesis. Biochem Biphys Acta 738: 9– 20, 1984 16 Cooper GM, Neiman E: Transforming genes of neoplasms induced by avian leukosis virus. Nature 287: 656– 659, 1980 17 Crawford L: The 53000 dalton cellular protein and its role in transformation. Int Rev Exp Path 25: 1– 50, 1983 18 Crawford LV, Pim DC, Bulbrook RD: Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30: 403– 408, 1982 19 Deleo AB, Jay G, Appelia E, Dubois GC, Law LW, Old LJ: Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells in the mouse. Proc Natl Acad Sci USA 76: 2420– 2424, 1979 20 Der CJ, Cooper GM: Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas. Cell 32: 201– 208, 1983 21 Der CJ, Krontiris TG, Cooper GM: Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras gene of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79: 3637– 3640, 1982 22 Dhar R, Nieto A, Koller R, DeFeo-Jones D, Scolnick EM: Nueleotide sequence of two rasH related-genes isolated from the yeast saccharomyces cerevisiae. Nucleic Acid Res 12: 3611– 3619, 1984 23 Doolittle RF, Hunkerpiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HW: Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet derived growth factor. Science 211: 275– 276, 1983 24 Downward J, Yardem Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, Waterfield MD: Close similarities of epidermal growth factor receptor and v-erb B oncogene protein sequences. Nature 307: 521– 527, 1984 25 Duesberg PH: Activated proto-onc genes: Sufficient or necessary for cancer? Science 228: 660– 677, 1985 26 Duesberg PH, Vogt PK: Differences between the ribonucleic acids of transforming and non-transforming avian tumour viruses. Proc Natl Acad Sci USA 67: 1673– 1680, 1970 27 Durst M, Gissman L, Ikenberg H, zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic reg ons. Proc Natl Acad Sci USA 80: 3812– 3815, 1983 28 Elias-Jones J, Hendy-Ibbs P, Cox H, Evan GI, Watson JV: Cervical brush biopsy specimens suitable for DNA and oncoprotein analysis using flow cytometry. J Clin Path 39: 577– 581, 1986 29 Eliyahu D, Raz A, Gruss P, Gival D, Oren M: Participation of p53 cellular tumour antigen in transformation of normal embryonal cells. Nature 312: 646– 649, 1984 30 Evan GI, Hancock DC: Studies on the interaction of the human c-myc protein with cell nuclei: p62c-myc as a member of a discrete subset of nuclear proteins. Cell 43: 253– 261, 1985 31 Evan GI, Lewis GK, Ramsay G, Bishop JM: Isolation of monoclonal antibodies specific for human and mouse proto-oncogene products. Mol Cell Biol 5: 3610– 3616, 1985 32 Favera DR, Wong-Staal F, Gallo R: Onc gene amplification in promyelocytic leukaemia cell line (HL-60) and in the primary from the same patiens. Nature 299: 61– 63, 1982 33 Friend M: Cell transformation ability of a temperature sensitive mutant of polyoma virus. Proc Natl Acad Sci USA 53: 486– 491, 1985 34 Fujii T, Crum CP, Winkler B, Fu YS, Richart RM: Human papillomavirus infection and cervical intraepithelial neoplasia: Histopathology and DNA content. Obstet Gynaecol 63: 99– 104, 1984 35 Furth ME, Davis LJ, Fleurdelys B, Scolnick E: Monoclonal antibodies to the p21 product of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J Virol 43: 294– 304, 1982 36 Gilbert F: Chromosome aberrations and oncogenes. Nature 303: 475, 1983 37 Gilman AG: G-proteins and dual control of adenylate cyclase. Cell 36: 577– 579, 1984 38 Graessman A, Graessman M, Tjian R, Topp WC: Simian virus 40 small-t protein is required for loss of actin cable network in rat cells. J Virol 33: 1182– 1191, 1980 39 Graham FL, van der Eb AJ: A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52: 456– 467, 1973 40 Greenberg ME, Ziff EB: Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433– 438, 1984 41 Gross L: Spontaneous leukaemia developing in C3H mice following innoculation, in infancy, with AK-leukaemia extracts, or AK-embryos. Proc Soc Exp Biol Med 76: 27– 32, 1951 42 Guerrero I, Villasante A, Corces V, Pellicer A: Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by γ-radiation. Science 225: 1159– 1162, 1984 43 Guerrero I, Villasante A, D'Eustachio P, Pellicer A: Isolation, characterization, and chromosome assignment of mouse N-ras gene from carcinogen-induced thymic lymphoma. Science 225: 1041– 1043, 1984 44 Hamlyn PH, Rabbitts TH: Translocation joins the c-myc and the immoglobulin γ1 genes in Burkitt's lymphoma revealing a third exon in the c-myc oncogene. Nature 304: 135– 139, 1983 45 Hanafusa, H, Haplern CC, Buckhagen DL, Kawai S: Recovery of avian sarcoma viruses from tumours induced by transformationdefective mutants. J Exp Med 146: 1735– 1747, 1977 46 Hann SR, Thompson CB, Eisemen RN: c-myc oncogene protein is independent of the cell cycle in human and avian cells. Nature 314: 366– 369, 1985 47 Harlow E, Crawford LV, Pim PC, and Williamson NM: Monoclonal antibodies specific for simian virus 40 tumour antigens. J Virol 39: 861– 869, 1981 48 Hayward WS, Neel BG, Ashin SM: Activation of a cellular onc gene by promotor insertion in ALV-induced lymphoid leukaemias. Nature 290: 475– 479, 1981 49 Headley DW, Friedlander MI, Taylor IW, Rugg CA, Musgrove EA: Method for analysis of cellular DNA content of paraffinembedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333– 1335, 1983 50 Hendy-Ibbs P, Cox H, Evan GI, Watson JV: Flow cytometric quantitation of DNA and c-myc oncoprotein in archival biopsies of uterine cervix neoplasia. (Submitted for publication), 1986 51 Hunter T: Oncogenes and proto-oncogenes: How do they differ? J Natl Cancer Inst 73: 773– 785, 1984 52 Hunter T, Cooper JA: Protein-tyrosine kinases. Ann Rev Biochem 54: 897– 930, 1985 53 Hunter T, Sefton BM: Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77: 1311– 1315, 1980 54 Hurley JB, Simon MI, Teplow DB, Robinsnaw JD, Gilman AG: Homologies between signal transducing G proteins and ras gene products. Science 226: 860– 863, 1984 55 Jenkins JR, Rudge K, Currie GA: Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature 312: 651– 654, 1984 56 Kelly K, Cochran BH, Stiles CD, Leder P: Cell specific regulation of the c-myc gene by lymphocyte mitogens and platelet derived growth factor. Cell 35: 603– 610, 1983 57 Kelly K, Cochran BH, Stiles CD, Leder P: The regulation of c-myc by growth signals. Curr Topics Microbiol Immum 113: 117– 126, 1984 58 de Klein A, Kessel AG, Grosveld G, Botram CR, Hagemeijer A, Groffen J, Stephenson JR: A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300: 765– 707, 1982 59 Koch R: Ueber Bakteriologische Forschung. Wein Med Bl 13: 531– 535, 1890. English translation Brit Med J ii: 380– 383, 1890. 60 Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495– 496, 1975 61 Kriegler M, Perez CF, Hardy C, Botchan M: Transformation mediated by the SV40 T-antigens; separation of the overlapping SV40 early genes with a retroviral vector. Cell 38: 483– 491, 1984 62 Krontiris, TG: The emerging genetics of human cancer. New Eng J Med 309: 404– 409, 1983 63 Kruijer W, Cooper JA, Hunter T, Verma IM: Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 711– 716, 1984 64 Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596– 602, 1983 65 Lane DP, Crawford LV: T-antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261– 263, 1979 66 Lee WW, Murphee AL, Benedict WF: Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309: 458– 460, 1984 67 Linden WA, Ochlich K, Baisch H, Scholz KU, Mauss HJ, Stegner HE, Joshi DS, Wu CT, Kaprowska I, Nicolini C: Flow cytometric prescreening of cervical smears. J Histochem Cytochem 27: 529– 535, 1979 68 Linzer DIH, Levine AJ: Characterization of a 54K Dalton cellular SV40 tumour antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17: 43– 52, 1979 69 Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD: Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306: 194– 196, 1983 70 Makino R, Hayashi KA, Sugimura T: c-myc is induced in rat liver at a very early stage of regeneration or by cycloheximide treatment. Nature 310: 697– 698, 1984 71 Martin GS: Rous sarcoma virus, a function required for the maintenance of the transformed state. Nature 227: 1021– 1023, 1970 72 McCarthy DM, Rassool FV, Goldman JM, Graham SV, Binnie GD: Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia. Lancet 2: 1362– 1365, 1984 73 McCormick F, Harlow E: Association of a murine 53,000 Dalton phosphoprotein with simian virus 40 large-T antigen in transformed cells. J Virol 34: 213– 224, 1980 74 Mercer WE, Avignol C, Baserga R: Role of p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Mol Cell Biol 4: 276– 281, 1984 75 Mercer WE, Nelson D, Deleo AB, Old LJ, Baserga R: Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells. Proc Natl Acad Sci USA 79: 6309– 6312, 1982 76 Miller AD, Curran T, Verma IM: c-fos protein can induce cellular transformation: A novel mechanism for activation of a cellular oncogene. Cell 36: 51– 60, 1984 77 Milner J: Different forms of p53 detected by monoclonal antibodies in non-dividing and dividing lymphocytes. Nature 310: 143– 145, 1984 78 Milner J, Cook A: Cellular tumour antigen p53; evidence for specific transformation related epitopes on p53 in transformed cells. Virology 153: (In press), 1986 79 Milner J, McCormick F: Lymphocyte stimulation: concanavalin A induces the expression of a 53K protein. Cell Biol (Int Rep) 4: 663– 667, 1980 80 Milner J, Milner S: SV40–53K antigen: A possible role for 53K in normal cells. Virology 112: 785– 788, 1981 81 Muller R, Bravo R, Burckhardt J, Curran T: Induction of c-fos gene and protein by growth factors preceeds activation of c-myc. Nature 312: 716– 720, 1984 82 Neel BG, Jhan War SC, Chaganti RSK, Hayward WS: Two human c-onc genes are located on the long arm of chromosome 8. Proc Natl Acad Sci :USA, 79: 7842– 7846, 1982 83 Niman HL, Houghten RA, Walker LE, Reisfeld RA, Wilson IA, Hogle JM, Lerner RA: Generation of protein-reactive antibodies by short peptides in an event of high frequency: Implications for the structural basis of immune recognition. Proc Natl Acad Sci USA 80: 4949– 4953, 1983 84 Niman HL, Thompson AMH, Yu A, Markman M, Willems JJ, Herwig KR, Habib NA, Wood CB, Houghton RA, Lerner RA: Anti-peptide antibodies detect oncogene-related proteins in urine. Proc Natl Acad Sci USA 82: 7724– 7928, 1985 85 Norris W: Case of fungoidal disease. Edinburgh Med Surg J 16: 562– 565, 1820 86 Oren M, Malzman W, Levine AJ: Post-translational regulation of the 54K cellular tumour antigen in normal and transformed cells. Mol Cell Biol 1: 101– 110, 1981 87 Parada LF, Land H, Weinberg RA, Wolf D, Rotter V: Co-operation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature 312: 649– 651, 1984 88 Papageorge AG, DeFeo-Jones D, Robinson P, Temeies G, Scolnick EM: Saccharomyces cervisiae synthesizes proteins related to the p21 ras found in mammals. Mol Cell Biol 4: 23– 29, 1984 89 Pfeiffer-Ohlsson S, Goustin AS, Rydnert J, Wahlstrom T, Bjersing L, Stehelin D, Ohlsson R: Spatial and temporal pattern of cellular myc oncogene expression in developing human placenta; Implications for embryonic cell proliferation. Cell 38: 585– 596, 1984 90 Powers S, Kataoka T, Fasano O, Goldfarb M, Strathern J, Broach J, Wigler M: Genes in S. cerevisiae encoding proteins with domains homologous to the mammalian ras proteins. Cell 36: 607– 612, 1984 91 Rabbitts PH, Watson JV, Lamond A, Fischer W, Forester A, Stinton MA, Evan GI, Atherton E, Sheppard RC, Rabbitts TH: Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. Embo J 4: 2009– 2015, 1985 92 Rassoulzadegan M, Cowie A, Carr A, Glaichenhous N, Karmen R: The role of individual polyoma virus early proteins in oncogenic transformation. Nature 300: 713– 718, 1982 93 Rassoulzadegan M, Naghashfar Z, Cowie A, Carr A, Grisoni M, Kamen R, Cuzin F: Expression of the large-T protein of polyoma virus promotes the establishment in culture of “normal” rodent fibroblast cell lines. Proc Natl Acad Sci 80: 4354– 4358, 1983 94 Reich NC, Levine AJ: Growth regulation of a cellular tumour antigen, p53, in non-transformed cells. Nature 308: 199– 201, 1984 95 Reich NC, Oren M, Levine AJ: Two distinct mechanisms regulate the level of a cellular tumour antigen, p53. Mol Cell Biol 3: 2143– 2150, 1983 96 Ribgy PW, Lane DP: Structure and function of Simian virus 40 large-T antigen. In: Advances in Viral Oncology, Volume 3, Klein George, (ed), Raven Press, New York, 1983, pp 31– 58 97 Riou G, Barrois M, Tordjman I, Dutronquay V, Orth G: Presence de genomes de papillomavirus et amplification des oncogenes c-myc et c-Ha-ras dans des cancers envahissants du col de l'uterus. CR Acad Sc Paris 299: 575– 580, 1985 98 Rohrschneider LR: Adhesion plaques of Rous sarcoma virus transformed cells contain the src gene product. Proc Natl Acad Sci 77: 3514– 3518, 1980 99 Rothberg PG, Erisman MD, Diehl RE, Roviatti UG, Astrin SM: Structure and expression of the oncogene c-myc in fresh tumour material from patients with heamopoetic malignancies. Mol Cell Biol 4: 1096– 1103, 1984 100 Rotter V: p53, a transformation-related cellular-encoded protein, can be used as a biochemical marker for the detection of primary mouse tumour cells. Proc Natl Acad Sci 80: 2613– 2617, 1983 101 Rotter V, Boss MA, Baltimore DJ: Increased concentration of an apparently identical cellular protein in cells transformed by either Ableson murine leukaemia or other transforming agents. J Virol 38: 336– 346, 1981 102 Rous P: Transmission of a malignant new growth by means of a cell-free filtrate. J Am (Chicago) 6: 198– 202, 1981 103 Roussel MF, Rettenmier CW, Look AT, Scherr CJ: Cell surface expression of v-fms-coded glycoproteins is required for transformation. Mol Cell Biol 4: 1999– 2009, 1984 104 Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243: 290– 293, 1973 105 Sarnow P, Ho YS, Williams J, Levine AJ: Adenovirus E1b-58K tumour antigen and SV40 large tumour antigen are physically associated with the same 54kd cellular protein in transformed cells. Cell 28: 387– 394, 1981 106 Schechter AL, Stern DF, Vaidyanathan L, Decker SJ, Drebin JA, Green MI, Weinberg RA: The neu oncogene: An erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature 312: 513– 517, 1984 107 Scherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER: The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocytic growth factor, CSF 1. Cell 41: 665– 676, 1985 108 Schwab M, Alitalo K, Klempenauer KH, Varmus HE, Bishop MJ, Gilbert F, Brodeur G, Goldstein M, Trent J: Amplified N-myc with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245– 248, 1983 109 Schwab M, Alitalo K, Varums HE, Bishop JM, George D: A cellular oncogene c-Ki-ras is amplified, overexpressed and located with karyotypic abnormalities in mouse adrenocortical tumour cells. Nature 303: 497– 501, 1983 110 Sefton BM, Hunter T, Ball EH, Singer SJ: Vinculin: a cytoskeletal target for the transforming protein of Rous sarcoma virus. Cell 24: 165– 174, 1981 111 Sikora K, Evan G, Stewart J, Watson JV: Detection of the c-myc oncogene product in testicular cancer. Br J Cancer 52: 171– 176, 1985 112 Slamon DJ, Dekernion JB, Verma IM, Cline MJ: Expression of cellular oncogenes in human malignancies. Science 224: 256– 262, 1984 113 Smeulders AW, Leyte-Veldstra L, Ploem JS, Cornelisse CJ: Texture analysis of cervical cell nuclei by segmentation of chromatin patterns. J Histochem Cytochem 27: 199– 208, 1979 114 Smith AE, Ely BK: The biochemical basis of transformation by polyoma virus. In: Advances in Viral Oncology, Volume 3, Klein George, (ed). Raven Press, New York, 1983, pp 3– 30 115 Southern EM: Detection of specific sequences among DNA fragments by gel electrophoresis. J Mol Biol 98: 503– 517, 1975 116 Spandidos DA, Agnantis NJ: Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene. Anticancer Research 4: 269– 272, 1984 117 Spandidos DA, Kerr IB: Elevated expression of the human ras oncogene family in premalignant tumours of the colorectum. Br J Cancer 49: 681– 688, 1984 118 Stehlin D, Varmus HE, Bishop JM, Vogt PK: DNA related to transforming genes of avian sarcoma virus is present in normal avian DNA. Nature 260: 170– 173, 1976 119 Stewart J, Evan GI, Watson JV, Sikora KE: Detection of the c-myc oncogene product in colonic polyps and carcinomas. Br J Cancer 53: 1– 6, 1986 120 Stewart SE, Eddy BE, Borgese NG: Neoplasms in mice inoculated with a tumour agent carried in tissue culture. J Natl Cancer Inst 20: 1223– 1243, 1958 121 Stewart TA, Bellve AR, Leder P: Transcription and promoter usage of the c-myc gene in normal somatic and spermatogenic cells. Science 226: 707– 710, 1984 122 Stewart TA, Pattengale PK, Leder P: Spontaneous mammary adenocarcinomas in transgenic mice carry and express MTV/myc fusion genes. Cell 38: 627– 637, 1984 123 Sukmar S, Notorio V, Martin-Zanca D, Barbacid M: Induction of mammary carcinomas in rats by nitros-methylurea involves malignant activation of H-ras-1 locus by single point mutation. Nature 306: 658– 661, 1983 124 Takeya T, Hanafusa H: Structure and sequence of the cellular gene homologous to the RSV src gene and the mechanism for generating the transforming virus. Cell 32: 881– 890, 1983 125 Temin H, Mizutani S: RNA-dependent DNA polymerase in virons of Rous sarcoma virus. Nature 226: 1211– 1213, 1970 126 Thomas PS: Hybridization of denatured RNA and small DNA fragments transfered to nitrocellulose. Proc Natl Acad Sci USA 77: 5201– 5205, 1980 127 Thompson CB, Challoner PB, Neiman PE, Groudine M: Levels of cmyc oncogene mRNA are invariate throughout the cell cycle. Nature 314: 363– 366, 1985 128 Thor A, Horan Hand P, Wunderlich D, Caruso A, Muraro R, Schlom J: Monoclonal antibodies define differential ras gene expression in malignant and benign colonic disease. Nature 311: 562– 564, 1984 129 Toda T, Uno I, Ishikawa T, Powers S, Kataoka T, Broek D, Cameron S, Broach J, Matsumoto K, Wigler M: In yeast, RAS proteins are controlling elements of adenylate cyclase. Cell 40: 27– 36, 1985 130 Tsou KC, Hong DH, Varello M, Giuntoll R, Wheeler JE, Atkinson BF, Mangan C, Mikuta J: Flow cytometric DNA analysis as a diagnostic aid for cervical condyloma and cancer. Cancer 54: 1778– 1787, 1984 131 Varmus HE: The molecular genetics of cellular oncogenes. Ann Rev Genet 18: 553– 612, 1984 132 Waterfield MD, Scrace GT, Whittle N, Stroobant P, Johnson A, Wasteson A, Westermark B, Huang J, Deuel TF: Platelet derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature 304: 35– 39, 1983 133 Watson JV: Enzyme kinetic studies in cell populations using fluorogenic substrates and flow cytometric techniques. Cytometry 1: 143– 151, 1980 134 Watson JV: Dual laser beam focussing for flow cytometry through a single crossed cylindrical lens pair. Cytometry 2: 14– 19, 1981 135 Watson JV: What does response in cancer chemotherapy really mean? Br Med J 283: 34– 37, 1981 136 Watson JV: A method for improving light collection by 600% from square cross section flow cytometry chambers. Br J Cancer 51: 433– 435, 1985 137 Watson JV, Stewart J, Cox H, Sikora KE, Evan GI: c-myc oncoprotein quantitation in colonic neoplasia. (Submitted for publication), 1986 138 Watson JV, Stewart J, Evan G, Ritson A, Sikora K: The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Br J Cancer 53: 331– 337, 1986 139 Watson JV, Sikora KE, Evan GI: A simultaneous flow cytometric assay for c-myc oncoprotein and cellular DNA in nuclei from paraffin embedded material. J Immunol Methods 83: 179– 192, 1985 140 Wheeless LL, Patten SF, Berkan TK, Brookes CL, Gorman KM, Lesh SR, Lopez PA, Wood JC: Multidimensional slit-scan prescreening system: preliminary results of a single blind clinical study. Cytometry 5: 1– 8, 1984 141 Weinberg RA: Use of transfection to analyse genetic information and malignant transformation. Biochem Biophys Acta 651: 25– 35, 1981 Citing Literature Volume7, Issue5September 1986Pages 400-410 ReferencesRelatedInformation